halobetasol
RxNorm concept 41208, ingredient (in).
- RxCUI
- 41208
- Term type
- Ingredient (IN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/41208 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- Ultravate (BN, has tradename)
- Bryhali (BN, has tradename)
- Lexette (BN, has tradename)
- Duobrii (BN, has tradename)
- halobetasol Topical Ointment (SCDF, ingredient of)
- halobetasol Topical Cream (SCDF, ingredient of)
- halobetasol propionate 0.0005 MG/MG (SCDC, ingredient of)
- halobetasol propionate 0.5 MG/ML (SCDC, ingredient of)
- halobetasol Topical Product (SCDG, ingredient of)
- halobetasol Topical Lotion (SCDF, ingredient of)
- halobetasol Topical Foam (SCDF, ingredient of)
- halobetasol propionate 0.1 MG/ML (SCDC, ingredient of)
- halobetasol / tazarotene Topical Product (SCDG, ingredient of)
- halobetasol / tazarotene Topical Lotion (SCDF, ingredient of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 41208 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/41208 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 41208. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.